BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Omeros Corporation Reports Third Quarter 2024 Financial Results

  November 14, 2024

   · 

  19 min read
• Press Releases

  AN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry Pipeline

  November 14, 2024

   · 

  12 min read
• Press Releases

  Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference

  November 14, 2024

   · 

  4 min read
• Press Releases

  Jasper Therapeutics to Participate at Upcoming Investor Conferences

  November 14, 2024

   · 

  4 min read
• Press Releases

  Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights

  November 14, 2024

   · 

  10 min read
• Press Releases

  Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

  November 14, 2024

   · 

  13 min read
• Press Releases

  Bluejay Diagnostics Announces Reverse Stock Split

  November 14, 2024

   · 

  4 min read
• Press Releases

  Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update

  November 14, 2024

   · 

  13 min read
• Press Releases

  Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 13, 2024

  November 14, 2024

   · 

  1 min read
• Press Releases

  Treatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss and nearly 99% remained diabetes-free at 176 weeks

  November 14, 2024

   · 

  21 min read